Percutaneous access device
AssigneesThermedics Inc., TMCA Foundation Inc.
InventorsVictor L. Poirier, Warren C. Clay, Benedict D. T. Daly
Life of this patent
Estimating the term…
Loading patent…
AssigneesThermedics Inc., TMCA Foundation Inc.
InventorsVictor L. Poirier, Warren C. Clay, Benedict D. T. Daly
Estimating the term…
Disclosed is a percutaneous access device (PAD) for long-term skin penetration and use as an access port in the body of a patient. The buttonlike device includes a flat skirt for subdermal anchoring of the PAD and a neck through which a tube may extend for transmission of materials to or from the body. A two-stage porous bed covering the skirt and at least a portion of the neck promotes formation of a tight, infection-free barrier between the percutaneous access device and adjacent tissues, stabilizing the device for long-term use. The first stage of the bed retards downgrowth of epidermal cells for a time sufficient for mature collagen to form in the second stage, thereby permitting the tight dermal/biomaterial interface or barrier to form at a location near the junction of the two stages.
In a percutaneous access deice including a button having a skirt and a neck integral with and substantially normal to said skirt, said neck and skirt being formed of a semirigid biocompatible material and having a bore therethrough to accommodate a tube, and a porous bed overlying and attached to at least a portion of said button, the improvement wherein said porous bed comprises a first stage extending along a portion of said skirt adjacent to said neck and along at least the lower portion of said neck and a second stage formed essentially of a biocompatible material and having pores of a size in the range of about 400-800 microns, said first stage having a total length along said neck and said skirt of at least 0.25 inches and being fabricated of layers of filaments of a diameter in the range of about 0.0004 to 0.015 inches and of a polyurethane material which is the reaction product of dicyclohexyl methane diisocyanate, polytetramethylene ether glycol, and 1,4 butane diol, said layers being formed into a structure having pores of a size in the range of about 50-125 microns, said percutaneous access device, upon implantation of the skirt in subcutaneous tissue adjacent to the dermis, promoting formation of a stable, tight, infection-free biologic seal between said device and adjoining tissue through the downgrowth of epidermal cells through the first stage and the formation of mature collagen in said second stage.
A percutaneous access device implantable in humans for periods of up to a year or longer to permit access to the body through the skin comprising:
Dependencies are inferred from the claim text.